CLINICAL_TRIALS
safety_alert
· 2016-05-16
Clinical Trial Update: Post Marketing Surveillance for Contac Bien Z in Japan
Summary
Post-marketing safety surveillance for Contac Bien Z in Japan has been completed. The surveillance evaluated safety in patients with allergic rhinitis and seaso…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Allergic Rhinitis, Seasonal Allergic Rhinitis | Status: COMPLETED